Fresh analysis reveals that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight far faster than those who end traditional lifestyle programs.
Research printed in a leading medical journal shows that while overweight individuals often shed substantial amounts of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying these treatments must be aware of the potential of rapid weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment mass in about one and a half years.
Weighing Approaches
The analysis, which looked at dozens of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.
Researchers note that individuals who lose weight through dieting usually have a less rapid weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Nutrition scientists believe the way of the injections explains the amplified regain.
GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines recommend the injections for people with weight-linked medical conditions, alongside recommended lifestyle changes.
Professionals say that, due to the significant potential of weight regain, the therapy is often life-long.
This view is reinforced by drug manufacturers, who say that the results "emphasize the persistent character of excess weight," comparing it to managing conditions like hypertension.
Patient Accounts
Users who have discontinued the medication describe a intense return of hunger.
"It felt as if something activating and you become extremely hungry," recalled one woman.
This difficulty is worsened if patients have not developed permanent lifestyle or habit changes during therapy.
Growing Interest
Recent estimates indicate that millions of people in the UK have tried these injections in the last 12 months, with desire being substantial.
- Use is higher among women compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
Finally, clinicians stress that while these medications are effective tools for weight loss, they are not a standalone cure and long-term success hinges on integrated behavioural management.
